Chronic Myeloid Leukemia Treatment Discontinuation
2 Vues
• 06/27/23
0
0
Intégrer
administrator
Les abonnés
The panelists, Jorge Cortes, MD; Kevin Kelly, MD, PhD; David Snyder, MD, FACP; Harry Erba, MD, PhD; and Javier Pinilla-Ibarz, MD, PhD, discuss under what conditions treatment discontinuation may be considered in the management of chronic myeloid leukemia.
Montre plus
Commentaires de Facebook
SORT BY-
Meilleures Commentaires
-
Derniers Commentaires